About this trial
The VAL-RAS-FR study aims to cross-culturally adapt, validate, and develop derived versions of the Recovery Assessment Scale (RAS), an internationally used self-report measure of subjective recovery in mental health. The study will include 260 adult psychiatric patients receiving care at EPSM Metz-Jury in both inpatient and outpatient settings. Participants will complete the French version of the RAS (RAS-FR), the WHOQOL-BREF, and additional self-report questionnaires. A subgroup of participants will complete the RAS-FR again after one month to assess test-retest reliability. The study will also explore existential aspects of recovery through the development of the RAS-FR-EX (Existential Extension) and support the development of a shorter version, the RAS-FR-SF (Short Form), for clinical and research purposes.
Eligibility criteria
Qualifiers
Adult patient (18 years or older)
Receiving psychiatric care at EPSM Metz-Jury (inpatient unit, day hospital, community mental health center [CMP], or intensive home-based psychiatric care service [EPSIAD]/post-EPSIAD follow-up)
Able to understand French
Able to complete a self-report questionnaire independently or with assistance if needed
Disqualifiers
Major cognitive impairment
Severe clinical condition preventing questionnaire completion or understanding of French
Refusal to participate
Prisoner or person deprived of liberty by judicial or administrative decision
Trial design
Treatments tested in this trial
- Self-report questionnaires
Treatment groups
Sponsors and collaborators
Etablissement Public de Santé Mentale de Metz-Jury
Lead sponsor
Centre Hospitalier Régional Metz-Thionville
Collaborator
Groupement Interrégional de Recherche Clinique et d'Innovation
Collaborator